4//SEC Filing
Ridha Essra 4
Accession 0001127602-22-027239
CIK 0001681087other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:34 PM ET
Size
5.2 KB
Accession
0001127602-22-027239
Insider Transaction Report
Form 4
AVROBIO, Inc.AVRO
Ridha Essra
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-08+183,000→ 183,000 totalExercise: $0.79Exp: 2032-12-07→ Common Stock (183,000 underlying)
Footnotes (1)
- [F1]50% of the shares shall vest and become exercisable on the first anniversary of the grant date, and the remaining 50% shall vest in equal monthly installments thereafter over a one-year period.
Documents
Issuer
AVROBIO, Inc.
CIK 0001681087
Entity typeother
Related Parties
1- filerCIK 0001888732
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:34 PM ET
- Size
- 5.2 KB